TCL Archive After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk December 13, 2002
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive President’s Cancer Panel To Meet In Hawaii Nov. 9 On centers; Committee Leans Toward New Cancer Control Cooperative Group August 24, 1984